Karus Therapeutics is a clinical-stage biopharmaceutical company developing highly-selective small-molecule drugs for cancer patients with unmet medical needs and limited treatment options.
Location: United Kingdom, England
Member count: 11-50
Total raised: $7.6M
Founded date: 2005
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 07.09.2012 | Series B | $7.6M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 18.12.2012 | The Babrah... | The Babraham Institute announc... | - | - | cambridgen... |
| 18.12.2012 | The Babrah... | The Babraham Institute and Kar... | - | - | cambridgen... |
| 07.09.2012 | Karus Ther... | Karus Therapeutics, a Chilwort... | funding U... | - | finsmes.co... |
| 06.09.2012 | Karus Ther... | SOUTHAMPTON, ENGLAND, Leader... | - | - | vcnewsdail... |